Royalty Pharma Sub-Manager, Llc Portfolio Stock Holdings

Royalty Pharma Sub-Manager, Llc disclosed 4 stock positions valued at approximately $172.8 million in its latest SEC 13F filing. The largest holdings include CYTOKINETICS, INC and BIOCRYST PHARMACEUTICALS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 14, 2026.

Report Period
March 31, 2026
No. of Stocks
4
Portfolio Value
$172.8M
Holdings by Sector
Royalty Pharma Sub-Manager, Llc Portfolio Holdings in Q1 2026

2 holdings in the latest reporting period.

Page 1 of 1
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
CYTOKINETICS, INCCYTKHealthcare37.40%980,392--$64,617,637
BIOCRYST PHARMACEUTICALS INCBCRXHealthcare21.19%3,846,154--$36,615,386